Concepedia

Publication | Open Access

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

DOIFull Paper Access

511

Citations

16

References

2016

Year

Jaskaran Singh, Maggie Fedgchin, Ella Daly, Peter de Boer, Kimberly Cooper, Pilar Lim, Christine Pinter, James W. Murrough, Gerard Sanacora, Richard C. Shelton,
American Journal of Psychiatry

Abstract

Twice-weekly and thrice-weekly administration of ketamine at 0.5 mg/kg similarly maintained antidepressant efficacy over 15 days.

References

YearCitations

Page 1